When does the peramivir patent expire?
Peramivir’s exact patent expiry date depends on the specific patent (and jurisdiction), because different patents can cover different aspects such as the active ingredient, formulations, or method-of-use. The provided information does not include any peramivir patent numbers, jurisdictions, or dates, so a precise “patent expires on” answer can’t be determined from it.
Does peramivir have a specific “key” patent date (active ingredient vs. formulation)?
Drug companies often hold multiple overlapping patents for a single product. For peramivir, the “active ingredient” patent may expire earlier or later than patents covering manufacturing, dosing forms, or other claims. Without the relevant patent list and the country (e.g., US, EU, Japan, China), it’s not possible to identify which patent date controls market exclusivity.
How is expiry different from marketing exclusivity?
Even after a patent expires, additional legal protections can keep a drug on exclusivity, such as regulatory data exclusivity or supplementary protection mechanisms (depending on country). Those are different from patent expiry and again require jurisdiction-specific details to calculate.
What do you need to look up the exact expiry date?
To pin down the peramivir patent expiry date, you typically need:
- The country/region (USPTO/US, EPO/Europe, Japan Patent Office, etc.)
- The patent number(s) or a link to the patent record
- Whether you want earliest patent expiry, last patent expiry, or exclusivity expiry
If you share the jurisdiction (for example, “US” or “EU”) and, if you have it, a patent number or the product marketing name, I can help you map it to the relevant expiry date based on the provided records.